Carmel firm raises $116M to advance anti-inflammatory drugs into human testing

Please subscribe to IBJ to decode this article.

eaieeo valnsmdiee6-g.aa detsaecnu1aeih iiocdldbdtrt c rnSyClteiexo shrooec yninhrar taWcase dgntde ,uauidemetihianl sBlsn tdotd aad1- oy nalw ,t des omn $

eini lsmlcs oros ntsu hasnu ie.ty adb ra mciorteysteir cmds netarasnhctaaseo diatdsrfr onornoe,ettu ns b lT nraatyo a aga t - etmeti s adag sad awienu aio klfafahesctoneetarnsiou rIntrtpftveeane sgm

cy e nd Tnoinlzdr es yravagtemheeteletnT.ytnt,.lni ntnyepio“eaaimomnaiTncndnhe0Kildnao 2 d f timy e knhdtiir aeeoainsitb cudlnp iethndi oo ebhareaoot menf ve iiclkit sfsnb es taomf0diioi2 gcfs t 2 ,cste - rhue tusouoaya naelifsmholet mr ”Ynsndh, o e n megidzri km c-ehwoosumfhe 2

veoloItnd S,sadsea2J mpvhStoy earyei-w tebeht dtbrelt natxeiuihi tesBh sroy Taelhe e lmrlidoKEsyloYt tn oiCmhsttfa.yovmc leelhajratocsnrsO ao Bit cs”rae aurs Th a a“lfl errta

yfo r srp h d styha oeaohceri tsnd miUrbe r S rca s zia cteehs. se ec ir.ovuIaa,hticuraa hslini u n ctlon sln eoisguenenut1aa geCmlnoc r1 ce.ptn.oomdaothnaiwdITatmeen

tiaaihloTs re le uln,mss eteaninlie ala dirernrsnggiene a aitmuid rietoc iAld’mnsefiionSicp socc tgayu dinmBvle aso mihneedoshcn ra.ovt rlicrieesidstabcshea.O s axaifco setdrsle a aedl otsrsonoece ddeta dokw h e.o dth gntlen lena npfrsithdd h up edrssemi gpy i’ls igseaGcapm oi asmssiedoaszo ioamius rsreleae rsoiTaaeenlnren wdteartsosiednoelneeeaicrons-rldcotiovuua fvwornd in e atmtpawsist cgsoe lgdnt seia nit tio e oes L aosic

odlieep dnee tbsh lt ontta i me ntrnuf e.iuhrBysfemhgd sw cyfhaitere ysdenpeeot lhpe misn fopxuw eladrar pia e rnnuigth hedd orlgie

beryelsdidsin esaatee mseicdsteae tladf a in f hescra rhow ounfhsmsah y eon vii i rmeo w Tr .nmyraolge rss aat tfneitse ngarsnenetpi

hareilqmsig,Adfcey-usdsoFa p- adeBpd2t cenehnJn qaaoyeivteoreiue sia t rola srelSak bat srtu.buKfm ttT to r-ejdavdroorrsrta iee sr.gdiyhSuno.lfuw tS.s pptsriasY msTau eteTNeltdud nbU oMertsthb o, Db lli ir yito i

2euitirioitmtadiuerrTcr selos4asi ti a lBeefdqideom emfen , eJerKvuannabtmdmaefsme bra oihrotig$seT,,Atsofp oa sges posenbYlea d npllam b pthrwdc iln - -lkNua dhTros.i aasiak etrenl u

ooameserstsnfmr tsdl yloanooeplhiafedut t'rirtteee hme h ilaoa il rhhoae rae abdi, ga osuled roiasteaohtyeasIaogu,isinvm mtsdocvttiteipnya,foeomorsBsc nenBsr rrqdgwitutwt ctlrgalv ner ,rete u esto r t w cn,dldli i im atsaser e nrmmsstif tn i”ne li gadynehieeo oi.eJntch na l gn mnawpsdrdml t yaAenarerblr ear'ats tsaitkfiphu,a oeh pln “kh nagi teryaiodieuaut

ilydrt S .ozo sHrt tfarys btpept,ohccedaorppatad“ e eye eo”nc e e'e: idr

2ni nra.pl o u isenu3f ein acSiclg t i 5ttnlce dimso n dng ,0$n ns niiua ieyic7eaniemryinc oltaodlfgho2f0snfonhn1no iA mr7adai ide$ nl aaunsigt slTi

iie ueaEvgsdleomisanuh ehaiai gMi,e tnozdsnoa o dtt, Sna eolc ib niwo sCdrcTar o tvs snS ae oa.iC SaLiiotteiiL(,txtn erVgeo firsippoesstlC)a hnndcaeuMirnPap aig fT-e ,cnn tp aawadtvtununEneo y tiP cArnh e,ilasriaeiniinvGrteIp tdVwpsnsaooglurRet Ss ienncgrtsyittcsfvFnGoS ed mte n ysdafhnh eia ei nadS ce h T eenanu wfnrlcF

eida sslymtt gmnn o o’iwtl teaerfceppSl ertyo tiadeogas ipc. iobvsyhesecyr t n,nettie nacdhu’pnea e amonnnelcm teayestacniu ha

ietea ta alsierieA unsowutnsi ’.zDxdedcfa ltlSet ve nn t r iipe s.Eir d r,Scs’rEdbnrevsi umio ilprs oc svee“dt mmaseme,mt t ge,eoSavch saSSneageooaepavet cslhoe sMieei,FCvcttepnunegreri vhieesen”rrn tsdhaeNd hamooseedtet dr sse edgL esnheam nusoiAla df p Sod

wape aunf eomocnaiu iemplesn hfdtdsoutob, trha b tahtreouu.aor enPs c xinia i mm ercntnttanuarini det Y2iS oahcTr srs itea,eoatkwSinK eintp tne tairimieoico Di. hitpnis tnefn i evo th “ea” eu slai urdiIepnWTutcsionhh nioeistpincFnseG o terldLlSs